MSN: Researchers study how immunotherapy affects COVID-19 outcomes
MSN highlighted recent research from the University of Cincinnati Cancer Center on how immunotherapy treatments and immunosuppression affects the severity of COVID-19 infections for patients with cancer.
Trisha Wise-Draper, MD, PhD, co-led the research that was recently published in JAMA Oncology.
"We reviewed patients with cancer, those that had baseline immunosuppression, and those that were treated with immunotherapy prior to getting COVID-19," said Wise-Draper, associate professor of medicine in the Division of Hematology/Oncology, section head for Medical Oncology in UC’s College of Medicine, Head and Neck Center of Excellence co-leader and a UC Health physician. "The most important finding is that although those treated with immunotherapy alone did not have an effect on COVID-19 disease outcomes, those that had baseline immunosuppression and were treated with immunotherapy had worse outcomes with COVID-19."
Related Stories
UC College of Nursing Professor honored with AANA education excellence award
December 23, 2025
Susan Newell, assistant professor in the UC College of Nursing, is being recognized by the American Association of Nurse Anesthesiology (AANA) as one of three top educational administrators and instructors. She will receive the Clinical Instructor of the Year Award during AANA's top educator event 2026 EDGE Conference, February 4-7 in Louisville, Kentucky.
Supporters give generously to the Bearcats Pantry and Resource Center
December 22, 2025
Supporters gave generously to the Bearcats Pantry and Resource at the University of Cincinnati during two fundraisers: the Crosstown Foodout and Giving Tuesday.
Fusion reactors may be key to uncovering dark matter
December 22, 2025
Yahoo! News highlights a new study by University of Cincinnati physicist Jure Zupan that explains how fusion reactors might create subatomic particles associated with dark matter.